Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -141,965 | -94,482 | -58,638 | -19,794 | -54,659 |
| Depreciation Amortization | 627 | 438 | 279 | 133 | 423 |
| Accounts receivable | 8,053 | 8,053 | 8,053 | -3,483 | 799 |
| Accounts payable and accrued liabilities | 4,305 | 7,756 | 8,105 | 4,500 | 10,210 |
| Other Working Capital | 24,792 | 12,523 | 11,609 | -2,549 | -8,331 |
| Other Operating Activity | 26,985 | 6,970 | -3,828 | 4,146 | -3,490 |
| Operating Cash Flow | $-77,203 | $-58,742 | $-34,420 | $-17,047 | $-55,048 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,292 | -664 | -536 | -218 | -628 |
| Purchase Of Investment | -132,259 | -132,260 | -125,520 | N/A | -49,347 |
| Sale Of Investment | 70,277 | 47,446 | 43,348 | 8,161 | 8,446 |
| Other Investing Activity | -1 | -1 | 0 | 0 | -2 |
| Investing Cash Flow | $-63,275 | $-85,479 | $-82,708 | $7,943 | $-41,531 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 135,973 | 129,440 | 129,440 | 129,440 | 2,215 |
| Financing Cash Flow | $135,973 | $129,440 | $129,440 | $129,440 | $2,215 |
| Beginning Cash Position | 43,044 | 43,044 | 43,044 | 43,044 | 137,408 |
| End Cash Position | 38,539 | 28,263 | 55,356 | 163,380 | 43,044 |
| Net Cash Flow | $-4,505 | $-14,781 | $12,312 | $120,336 | $-94,364 |
| Free Cash Flow | |||||
| Operating Cash Flow | -77,203 | -58,742 | -34,420 | -17,047 | -55,048 |
| Capital Expenditure | -1,292 | -664 | -536 | -218 | -628 |
| Free Cash Flow | -78,495 | -59,406 | -34,956 | -17,265 | -55,676 |